Regenxbio (RGNX) Non Operating Interest Expenses (2014 - 2026)
Regenxbio (RGNX) reported Non Operating Interest Expenses of $7.79 million for Q2 2026, down 29.1% from $10.99 million a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Non Operating Interest Expenses (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Regenxbio's Non Operating Interest Expenses came in at $44.23 million, up 48.4% year-over-year; for FY2025, it came in at $45.01 million, up 255.5% from FY2024.
- Non Operating Interest Expenses has a five-year compound annual growth rate of 125.6% (FY2020 to FY2025).
- By year, Non Operating Interest Expenses came in at $12.66 million in FY2024 (+84.5%), $6.86 million in FY2023 (-70.5%), $23.25 million in FY2022 (-11.5%) and $26.28 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Non Operating Interest Expenses since Q3 2024.
- Year over year, Non Operating Interest Expenses gained in three of the last five quarters, with growth averaging 175.4%.
- The high point for year-over-year Non Operating Interest Expenses in five years was Q4 2024 (growth of 590.9%); the low point was Q2 2023 (a decline of 83.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Regenxbio | 407.85 Mn | -525.24 Mn | - | 7.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.79 Mn |
| Dec 31, 2025 | 12.28 Mn |
| Sep 30, 2025 | 13.17 Mn |
| Jun 30, 2025 | 10.99 Mn |
| Mar 31, 2025 | 8.57 Mn |
| Dec 31, 2024 | 9.42 Mn |
| Sep 30, 2024 | 820,000.00 |
| Jun 30, 2024 | 449,000.00 |
| Mar 31, 2024 | 1.97 Mn |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 1.62 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 2.76 Mn |
| Dec 31, 2022 | 4.31 Mn |
| Sep 30, 2022 | 5.95 Mn |
| Jun 30, 2022 | 6.86 Mn |
| Mar 31, 2022 | 6.13 Mn |
| Dec 31, 2021 | 6.50 Mn |
| Sep 30, 2021 | 6.71 Mn |
| Jun 30, 2021 | 6.37 Mn |
API Access
Regenxbio Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();